Date: 2025/04/02 - 23:32
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/04/02 - 23:00
The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain affordable weight loss medications. Here, two people who've relied on compounded GLP-1 drugs share their stories.
Date: 2025/03/30 - 18:32
While CRC is on the rise in people under 50, receiving colonoscopies beginning at age 45 can help decrease your risk. Additionally, making lifestyle changes can also help reduce your risk for CRC.
Date: 2025/03/29 - 10:31
New-onset type 2 diabetes was linked to an increased risk for developing certain cancers typically related to obesity, including colorectal, pancreatic, and liver cancers. This increased risk was greater in men than in women.
Date: 2025/03/20 - 00:00
The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now that the GLP-1 drug shortage has ended. People who rely on compounded GLP-1s say they may not be able to afford brand-name versions, which are often not covered by insurance.